End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54,300 KRW | +0.93% | +15.53% | +43.84% |
2023 | Tranche Update on CLASSYS Inc.'s Equity Buyback Plan announced on September 15, 2022. | CI |
2023 | Tranche Update on CLASSYS Inc.'s Equity Buyback Plan announced on September 15, 2022. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.55 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+43.84% | 2.52B | - | ||
+7.19% | 220B | B | ||
+9.32% | 196B | B- | ||
+25.69% | 152B | B- | ||
+32.59% | 114B | A- | ||
+2.97% | 66.49B | A- | ||
+14.64% | 52.89B | B+ | ||
+1.91% | 49.48B | B+ | ||
-5.97% | 38.85B | A | ||
-1.16% | 34.68B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A214150 Stock
- Ratings CLASSYS Inc.